Cargando…
Gut Microbial Metabolite Pravastatin Attenuates Intestinal Ischemia/Reperfusion Injury Through Promoting IL-13 Release From Type II Innate Lymphoid Cells via IL−33/ST2 Signaling
Intestinal ischemia/reperfusion (I/R) injury is a grave condition with high morbidity and mortality. We previously confirmed that intestinal I/R induces intestinal flora disorders and changes in metabolites, but the role of different metabolites in intestinal I/R injury is currently unclear. Based o...
Autores principales: | Deng, Fan, Hu, Jing-Juan, Yang, Xiao, Sun, Qi-Shun, Lin, Ze-Bin, Zhao, Bing-Cheng, Yao, Zhi-Wen, Luo, Si-Dan, Chen, Ze-Ling, Liu, Ying, Yan, Zheng-Zheng, Li, Cai, Liu, Wei-Feng, Liu, Ke-Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505964/ https://www.ncbi.nlm.nih.gov/pubmed/34650552 http://dx.doi.org/10.3389/fimmu.2021.704836 |
Ejemplares similares
-
A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
por: Salimi, Maryam, et al.
Publicado: (2013) -
IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis
por: Miller, Jessica E., et al.
Publicado: (2021) -
IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012) -
IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice
por: Li, Dong, et al.
Publicado: (2014) -
Prostaglandin I2 inhibits IL-33-induced IL-5 and IL-13 production by human type 2 innate lymphoid cells
por: Zhou, Weisong, et al.
Publicado: (2015)